The University of Miami today announced a transformational $50 million gift from Kenneth C. Griffin, Founder and Chief Executive Officer of Citadel and Founder of Griffin Catalyst, to Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and the Miller School of Medicine. The gift will double Sylvester’s research footprint, accelerating efforts to develop new therapies, enhancing care for patients, and expanding access to clinical trials in a new 12-story, 244,000-square-foot facility set to open in 2025.
In recognition of the gift, which is part of the University’s $2.5 billion Ever Brighter fundraising campaign, the facility will be named the Kenneth C. Griffin Cancer Research Building.
This landmark gift advances our sophisticated and comprehensive cancer research efforts. With bench scientists and clinicians co-localized, we can deliver on the promise of precision medicine and enable even more families in the region to benefit from novel life-saving treatments. This building demonstrates Sylvester’s commitment to our community and its dedication to reducing the burden of cancer in our nation.”Â
Dr. Stephen D. Nimer, director of Sylvester, Oscar de la Renta Endowed Chair in cancer research and executive dean for research at the Miller School
“Sylvester’s team of physicians, scientists, and healthcare professionals plays a leading role in our community’s efforts to defeat cancer,” said Griffin. “I am honored to support the transformational work of these incredible individuals in discovering, developing, and delivering life-saving treatments to those affected by this disease in South Florida and beyond.”
One of the country’s leading philanthropists, Griffin has long been committed to pushing the frontiers of science and medicine to drive progress and improve lives. His efforts have included major contributions to Memorial Sloan Kettering Cancer Center, Nicklaus Children’s Hospital, and the Michael J. Fox…
